The Successful Treatment of a Case of HCV-associated Cryoglobulinemic Glomerulonephritis with Rituximab, Direct-acting Antiviral Agents, Plasmapheresis and Long-term Steroid Despite Serologically Persistent Cryoglobulinemia

Novel treatments with rituximab or direct-acting antiviral agents (DAAs) were expected to improve the clinical outcomes of hepatitis C virus (HCV)-associated cryoglobulinemia in the last decade. Recently, however, persistent cases of cryoglobulinemia have been reported, and the ideal approach to tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Muro, Koji, Toda, Naohiro, Yamamoto, Shinya, Yanagita, Motoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946495/
https://www.ncbi.nlm.nih.gov/pubmed/32999232
http://dx.doi.org/10.2169/internalmedicine.5461-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946495/
https://www.ncbi.nlm.nih.gov/pubmed/32999232
http://dx.doi.org/10.2169/internalmedicine.5461-20

Ejemplares similares